Dr. Blackman co-founded Day One Biopharmaceuticals in 2018 with a vision to identify, acquire, and develop promising new treatments to address childhood cancers. Under Dr. Blackman’s leadership, Day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback